Ubs Asset Management Americas Inc Immunome Inc. Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Immunome Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 112,298 shares of IMNM stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,298
Previous 186,698
39.85%
Holding current value
$1.92 Million
Previous $1.74 Million
25.06%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IMNM
# of Institutions
166Shares Held
71.5MCall Options Held
325KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.42MShares$144 Million0.06% of portfolio
-
Redmile Group, LLC San Francisco, CA5.02MShares$86.1 Million6.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$83.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.82MShares$82.7 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$69.9 Million3.55% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $208M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...